Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
<p>Abstract</p> <p>Background</p> <p>This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).</p> <p>Methods...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2466/12/31 |
id |
doaj-eb18d6da87bc4ea1acf41a0d1fe43fa2 |
---|---|
record_format |
Article |
spelling |
doaj-eb18d6da87bc4ea1acf41a0d1fe43fa22020-11-24T23:39:29ZengBMCBMC Pulmonary Medicine1471-24662012-06-011213110.1186/1471-2466-12-31Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanismsHaren Matthew TMisan GaryPaterson Tracey-JayneRuffin Richard EGrant Janet FBuckley Jonathan DHowe Peter RCNewbury JonathanTaylor Anne WMcDermott Robyn A<p>Abstract</p> <p>Background</p> <p>This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).</p> <p>Methods</p> <p>A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009). Seven-hundred twenty-two randomly selected adults (≥18 years) completed clinical protocols (32.2% response rate). Lung function was measured by spirometry. Post-bronchodilator FEV<sub>1</sub>/FVC was used to measure airway obstruction and reversibility of FEV<sub>1</sub> was calculated. Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma. Symptom scores for asthma (CASS) and SDB were calculated. Intra-abdominal fat (IAF) was estimated using dual-energy x-ray absorptiometry (DXA). IR was calculated from fasting glucose and insulin concentrations.</p> <p>Results</p> <p>The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 – 23.5%). The ratio of observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9). IAF was not associated with current doctor-diagnosed asthma, FEV<sub>1</sub>/FVC or FEV<sub>1</sub> reversibility in men or women but was positively associated with CASS independent of IR and SDB in women. A 1% increase in IAF was associated with decreases of 12 mL and 20 mL in FEV<sub>1</sub> and FVC respectively in men, and 4 mL and 7 mL respectively in women. SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women.</p> <p>Conclusions</p> <p>In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma symptoms which did not correlate with lower FEV<sub>1</sub>. Higher IAF was significantly associated with lower FEV<sub>1</sub> and FVC and in men SDB mechanisms may contribute up to one quarter of this association.</p> http://www.biomedcentral.com/1471-2466/12/31Airway obstructionForced Expiratory VolumeForced Vital CapacityAsthmaAbdominal adipositySleep disordered breathing |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Haren Matthew T Misan Gary Paterson Tracey-Jayne Ruffin Richard E Grant Janet F Buckley Jonathan D Howe Peter RC Newbury Jonathan Taylor Anne W McDermott Robyn A |
spellingShingle |
Haren Matthew T Misan Gary Paterson Tracey-Jayne Ruffin Richard E Grant Janet F Buckley Jonathan D Howe Peter RC Newbury Jonathan Taylor Anne W McDermott Robyn A Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms BMC Pulmonary Medicine Airway obstruction Forced Expiratory Volume Forced Vital Capacity Asthma Abdominal adiposity Sleep disordered breathing |
author_facet |
Haren Matthew T Misan Gary Paterson Tracey-Jayne Ruffin Richard E Grant Janet F Buckley Jonathan D Howe Peter RC Newbury Jonathan Taylor Anne W McDermott Robyn A |
author_sort |
Haren Matthew T |
title |
Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms |
title_short |
Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms |
title_full |
Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms |
title_fullStr |
Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms |
title_full_unstemmed |
Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms |
title_sort |
abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms |
publisher |
BMC |
series |
BMC Pulmonary Medicine |
issn |
1471-2466 |
publishDate |
2012-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).</p> <p>Methods</p> <p>A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009). Seven-hundred twenty-two randomly selected adults (≥18 years) completed clinical protocols (32.2% response rate). Lung function was measured by spirometry. Post-bronchodilator FEV<sub>1</sub>/FVC was used to measure airway obstruction and reversibility of FEV<sub>1</sub> was calculated. Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma. Symptom scores for asthma (CASS) and SDB were calculated. Intra-abdominal fat (IAF) was estimated using dual-energy x-ray absorptiometry (DXA). IR was calculated from fasting glucose and insulin concentrations.</p> <p>Results</p> <p>The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 – 23.5%). The ratio of observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9). IAF was not associated with current doctor-diagnosed asthma, FEV<sub>1</sub>/FVC or FEV<sub>1</sub> reversibility in men or women but was positively associated with CASS independent of IR and SDB in women. A 1% increase in IAF was associated with decreases of 12 mL and 20 mL in FEV<sub>1</sub> and FVC respectively in men, and 4 mL and 7 mL respectively in women. SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women.</p> <p>Conclusions</p> <p>In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma symptoms which did not correlate with lower FEV<sub>1</sub>. Higher IAF was significantly associated with lower FEV<sub>1</sub> and FVC and in men SDB mechanisms may contribute up to one quarter of this association.</p> |
topic |
Airway obstruction Forced Expiratory Volume Forced Vital Capacity Asthma Abdominal adiposity Sleep disordered breathing |
url |
http://www.biomedcentral.com/1471-2466/12/31 |
work_keys_str_mv |
AT harenmatthewt abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT misangary abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT patersontraceyjayne abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT ruffinricharde abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT grantjanetf abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT buckleyjonathand abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT howepeterrc abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT newburyjonathan abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT taylorannew abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms AT mcdermottrobyna abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms |
_version_ |
1725513230829223936 |